Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to evaluate the association between post-coronary angiography IMR and medium-term clinical prognosis in patients with acute myocarditis. The main question it aims to answer is:
Is there a correlation between impaired microcirculation and the occurrence of serious clinical events in this population of patients?
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Coronary catheterization | Procedure | Coronary catheterization |
| Measure | Description | Time Frame |
|---|---|---|
| MACE | The primary endpoint is the 1-year incidence rate of MACE. MACE is defined by a composite endpoint comprising: 1) all-cause mortality, 2) cardiac decompensation requiring readmission, 3) heart transplantation, 4) documented sustained ventricular arrhythmia lasting >30 seconds, and 5) recurrence of myocarditis. | From the time of the coronary angiography up to one year |
| Measure | Description | Time Frame |
|---|---|---|
| Individual components of the 12-month MACE: cardiovascular death, transplantation, hospitalization for heart failure, and persistent heart failure (reported separately) | From the time of the coronary angiography up to one year | |
| Correlation between IMR angiographic NH (continuous variable) and: a) MRI imaging criteria (LVEF, fibrosis, septal involvement, edema); b) biological markers (maximum troponin, CRP) |
Not provided
Inclusion Criteria:
Male or female patients over the age of 18.
Patients hospitalized between June 2015 and July 2025.
Patients who presented with chest pain and at least 1 diagnostic criterion; or, in the absence of chest pain, at least 2 of the following diagnostic criteria:
Associated with MRI findings of ≥2 tissue abnormalities (edema, hyperemia, myocardial fibrosis).
Coronary angiography performed during the initial hospitalization
Patient enrolled in or eligible for a social security program.
Patient who has expressed consent to participate.
Exclusion Criteria:
Not provided
Not provided
Not provided
patients hospitalized in the cardiology department at CHUGA between 2015 and 2025 who had a diagnosis of myocarditis confirmed by cardiac MRI.
Not provided
Not provided
Not provided
Not provided
| From the time of the coronary angiography up to one year |
| Predictive value of MRI angiography: diagnostic performance in predicting the primary endpoint (ROC, optimal cut-off values, sensitivity/specificity) | From the time of the coronary angiography up to one year |
| Assessment of inter- and intra-observer reproducibility of the MR angiography NH calculation (if a subsample is reanalyzed) | From the time of the coronary angiography up to one year |